Skip to main content

Table 2 Characteristics of patients with different histological types of appendiceal cancer

From: Chemotherapy in the treatment of different histological types of appendiceal cancers: a SEER based study

Variable

 

Histological Types

 

P value

 

GCC

(n = 1087)

MAC

(n = 2831)

SRCC

(n = 575)

NECs

(n = 421)

NETs

(n = 1667)

NMAC

(n = 1762)

MiNENs

(n = 390)

 

Age

 Mean ± SD

56.5 ± 13.6

59.6 ± 14.2

59.8 ± 12.7

45.7 ± 17.3

44.9 ± 17.8

62.8 ± 14.8

58.4 ± 12.

< 0.0001

 Median (range)

56 (18–99)

60 (19–98)

59 (27–94)

46 (18–94)

44 (18–95)

63 (19–97)

58 (20–89)

 

  ≤ 56

552 (50.8)

1181 (41.7)

243 (42.3)

300 (71.3)

1199 (71.9)

591 (33.5)

170 (43.6)

< 0.0001

  > 56

535 (49.2)

1650 (58.3)

332 (57.7)

121 (28.7)

468 (28.1)

1171 (66.5)

220 (56.4)

 

Gender

 Male

529 (48.7)

1272 (44.9)

238 (41.4)

156 (37.1)

642 (38.5)

912 (51.8)

198 (50.8)

< 0.0001

 Female

558 (51.3)

1559 (55.1)

337 (58.6)

265 (63)

1025 (61.5)

850 (48.2)

192 (49.2)

 

Marital status

 Married

650 (59.8)

1787 (63.1)

357 (62.1)

197 (46.8)

792 (47.5)

1041 (59.1)

243 (62.3)

< 0.0001

 Unmarrieda

386 (35.5)

946 (33.4)

194 (33.7)

182 (43.2)

769 (46.1)

655 (37.2)

130 (33.3)

 

 Unknown

51 (4.7)

98 (3.5)

24 (4.2)

42 (10)

106 (6.4)

66 (3.8)

17 (4.4)

 

Race

 African American

103 (9.5)

256 (9)

55 (9.6)

34 (8.1)

135 (8.1)

236 (13.4)

35 (9)

< 0.0001

 White

938 (86.3)

2341 (82.7)

478 (83.1)

359 (85.3)

1447 (86.8)

1395 (79.2)

341 (87.4)

 

 Other

40 (3.7)

223 (7.9)

41 (7.1)

17 (4)

60 (3.6)

122 (6.9)

12 (3.1)

 

 Unknown

6 (0.6)

11 (0.4)

1 (0.2)

11 (2.6)

25 (1.5)

9 (0.5)

2 (0.5)

 

Region

 West

467 (43)

1506 (53.2)

275 (47.8)

171 (40.6)

782 (46.9)

820 (46.5)

164 (42.1)

< 0.0001

 South

271 (24.9)

585 (20.7)

132 (23)

110 (26.1)

417 (25)

467 (26.5)

96 (24.6)

 

 Midwest

120 (11)

252 (8.9)

45 (7.8)

52 (12.4)

140 (8.4)

153 (8.7)

62 (15.9)

 

 Northwest

229 (21.1)

488 (17.2)

123 (21.4)

88 (20.9)

328 (19.7)

322 (18.3)

68 (17.4)

 

CEA

 Negative

121 (11.1)

430 (15.2)

145 (25.2)

2 (0.5)

0 (0)

348 (19.8)

80 (20.5)

< 0.0001

 Positive

40 (3.7)

671 (23.7)

100 (17.4)

2 (0.5)

0 (0)

254 (14.4)

30 (7.7)

 

 Unknown

926 (85.2)

1730 (61.1)

330 (57.4)

417 (99.1)

1667 (100)

1160 (65.8)

280 (71.8)

 

Deposit

 Negative

470 (43.2)

866 (30.6)

158 (27.5)

2 (0.5)

0 (0)

564 (32)

162 (41.5)

< 0.0001

 Positive

21 (1.9)

176 (6.2)

82 (14.3)

2 (0.5)

0 (0)

123 (7)

34 (8.7)

 

 Unknown

596 (54.8)

1789 (63.2)

335 (58.3)

417 (99.1)

1667 (100)

1075 (61)

194 (49.7)

 

Tumor size

  < 2 cm

383 (35.2)

260 (9.2)

44 (7.7)

277 (65.8)

1400 (84)

312 (17.7)

66 (16.9)

< 0.0001

  ≥ 2 cm

392 (36.1)

1456 (51.4)

334 (58.1)

119 (28.3)

240 (14.4)

927 (52.6)

200 (51.3)

 

 Unknown

312 (28.7)

1115 (39.4)

197 (34.3)

25 (5.9)

27 (1.6)

523 (29.7)

124 (31.8)

 

Harvested lymph nodes

  ≤ 12

624 (57.4)

1589 (56.1)

282 (49)

284 (67.5)

1288 (77.3)

880 (49.9)

151 (38.7)

< 0.0001

  > 12

457 (42)

1199 (42.4)

286 (49.7)

130 (30.9)

364 (21.8)

855 (48.5)

236 (60.5)

 

 Unknown

6 (0.6)

43 (1.5)

7 (1.2)

7 (1.7)

15 (0.9)

27 (1.5)

3 (0.8)

 

T stage

 T1

108 (9.9)

233 (8.2)

20 (3.5)

293 (69.6)

1416 (84.9)

143 (8.1)

11 (2.8)

< 0.0001

 T2

137 (12.6)

180 (6.4)

14 (2.4)

48 (11.4)

152 (9.1)

204 (11.6)

13 (3.3)

 

 T3

649 (59.7)

783 (27.7)

188 (32.7)

48 (11.4)

80 (4.8)

723 (41)

209 (53.6)

 

 T4

193 (17.8)

1635 (57.8)

353 (61.4)

32 (7.6)

19 (1.1)

692 (39.3)

157 (40.3)

 

N stage

 N0

950 (87.4)

2387 (84.3)

289 (50.3)

337 (80.1)

1534 (92)

1236 (70.2)

251 (64.4)

< 0.0001

 N1

91 (8.4)

291 (10.3)

136 (23.7)

72 (17.1)

128 (7.7)

312 (17.7)

66 (16.9)

 

 N2

46 (4.2)

153 (5.4)

150 (26.1)

12 (2.9)

5 (0.3)

214 (12.2)

73 (18.7)

 

M stage

 M0

1003 (92.3)

1608 (56.8)

285 (49.6)

397 (94.3)

1646 (98.7)

1377 (78.2)

288 (73.9)

< 0.0001

 M1

84 (7.7)

1223 (43.2)

290 (50.4)

24 (5.7)

21 (1.3)

385 (21.9)

102 (26.2)

 

Grade

 Well differentiated

165 (15.2)

1054 (37.2)

11 (1.9)

304 (72.2)

1201 (72.1)

244 (13.9)

36 (9.2)

< 0.0001

 Moderately differentiated

142 (13.1)

973 (34.4)

35 (6.1)

50 (11.9)

136 (8.2)

928 (52.7)

56 (14.4)

 

 Poorly or un-differentiated

88 (8.1)

296 (10.5)

381 (66.3)

31 (7.4)

9 (0.5)

441 (25)

157 (40.3)

 

 Unknown

692 (63.7)

508 (17.9)

148 (25.7)

36 (8.6)

321 (19.3)

149 (8.5)

141 (36.2)

 

Surgery

 Less than hemicolectomy

489 (45)

983 (34.7)

167 (29)

246 (58.4)

1216 (73)

619 (35.1)

127 (32.6)

< 0.0001

 Hemicolectomy or more

561 (51.6)

1631 (57.6)

366 (63.7)

151 (35.9)

380 (22.8)

1064 (60.4)

253 (64.9)

 

 Other

37 (3.4)

217 (7.7)

42 (7.3)

24 (5.7)

71 (4.3)

79 (4.5)

10 (2.6)

 

Chemotherapy

 No

927 (85.3)

1518 (53.6)

207 (36)

400 (95)

1640 (98.4)

1046 (59.4)

219 (56.2)

< 0.0001

 Yes

160 (14.7)

1313 (46.4)

368 (64)

21 (5)

27 (1.6)

716 (40.6)

171 (43.9)

 

Cancer specific death

 No

968 (89.1)

2135 (75.4)

313 (54.4)

403 (95.7)

1656 (99.3)

1259 (71.5)

290 (74.4)

< 0.0001

 Yes

119 (11)

696 (24.6)

262 (45.6)

18 (4.3)

11 (0.7)

503 (28.6)

100 (25.6)

 

Overall death

 No

837 (77)

1779 (62.8)

221 (38.4)

372 (88.4)

1605 (96.3)

930 (52.8)

256 (65.6)

< 0.0001

 Yes

250 (23)

1052 (37.2)

354 (61.6)

49 (11.6)

62 (3.7)

832 (47.2)

134 (34.4)

 
  1. aUnmarried status including, divorced, separated, widowed and unmarried. CI confidence interval; HR hazard ratio; SRCC signet ring cell carcinoma; MAC mucinous adenocarcinomas; NMAC non-mucinous adenocarcinoma; MiNENs mixed neuroendocrine non-neuroendocrine neoplasms; GCC goblet cell carcinoma; NETs neuroendocrine tumors; NECs, neuroendocrine carcinomas